Viewing Study NCT07020260


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-06-14 @ 11:09 AM
Study NCT ID: NCT07020260
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-13
First Post: 2025-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies
Sponsor: Princess Maxima Center for Pediatric Oncology
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2023-507597-40
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None INDUSTRY View
None UNKNOWN View